Kallisio Stentra™ Named “Best New Radiology Technology Solution” in 2026 MedTech Breakthrough Awards Program | Business
Publish Date: 2026-05-07 11:01:00
Source Domain: www.rutlandherald.com
BALTIMORE–(BUSINESS WIRE)–May 7, 2026–
Kallisio, a company focused on advancing precision oncology through patient-specific, technology-enabled solutions, today announced that Stentra ™ has received “Best New Radiology Technology Solution” in the 10 th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and medical technology market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507479243/en/
FDA-cleared Stentra™ patient-tailored oral immobilization solution delivers a custom fit and case-specific tongue displacement to optimize dose delivery and protect healthy tissues in head and neck cancer radiation therapy.
“Kallisio redefines how precision oncology solutions are designed, governed, and scaled. Radiation should treat cancer without the risk of compromising healthy tissue, but inconsistent immobilization can lead to patient risk. Generic or handcrafted oral appliances are variable in quality, contributing to toxicities, treatment interruptions, and operational inefficiencies,” said Steve Johansson, managing director, MedTech Breakthrough. “Kallisio’s Stentra transforms variability into precision. Combining leadership, evidence, and economic relevance, Stentra is not just digital health; it is digitally enabled medical technology with proven real-world impact.”
FDA-cleared and CE-marked, Kallisio’s governance-ready Stentra solution combines optical scanning, automated design, and rapid additive manufacturing to deliver millimeter-accurate, 3D-printed devices built specifically for head and neck cancer patient’s oral anatomy and radiation treatment plan. Stentra effectively…
